News Releases

 
NYSE Lists Nine New HealthSharesTM ETFs
   Tracking Healthcare, Life Science and Biotechnology

New York  , Mar. 12, 2007–NYSE Group, Inc. (NYSE: NYX) today announced that the latest additions to the HealthShares™ family of exchange traded products, nine new HealthShares™ ETFs, began trading on the Big Board. The initial five HealthShares™ ETFs began trading on the NYSE on Jan. 23, 2007

“We are pleased to add these new HealthShares™ listings and expand our partnership with XShares Advisors LLC,” said NYSE Group Senior Vice President, Exchange Traded Funds and Indexes, Lisa Dallmer. “These products further solidify the NYSE Group’s strong placement in the growing ETF market and our commitment to offering investors the most diverse mix of products with the highest level of market quality.”

“We are excited to add another nine ETFs to our HealthSharesä family of funds,” said Jeffrey L. Feldman, Chairman and Founder, XShares Group LLC.  “Like our previously launched HealthSharesä ETFs, these funds are new investment tools that focus on specific therapeutic areas or sub-segments of healthcare, investing in innovative companies that are rarely featured in competing healthcare portfolios.  We now offer a total of fourteen innovative ETFs that investors can use to create flexible and well-diversified investment portfolios.”

Fund Name

Ticker

Metabolic-Endocrine Disorders Index

HHM

Autoimmune-Inflammation Index

HHA

Cancer Index

HHK

Cardiology Index

HRD

Composite Index

HHQ

GI / Gender Health Index

HHU

Respiratory/ Pulmonary Index

HHR

Neuroscience Index

HHN

Ophthalmology Index

HHZ

Including today’s new listings, NYSE Group markets have 175 primary ETF listings and trade all other eligible ETFs on a UTP basis.   In 2006, NYSE Group handled over 43% of all ETF shares traded in the U.S. market.    As the largest exchange for ETF trading, NYSE Group is committed to offering investors the most innovative new investment options with superior pricing and market quality.

For more information and data on NYSE Group listed ETFs and other products, please visit: http://www.nyse.com/etfs.

About HealthShares
XShares Advisors LLC, a financial services company based in New York , is the creator of the HealthSharesä family of Exchange Traded Funds (ETFs). HealthSharesä ETFs are organized into therapeutic ‘Verticals’ and represent specific areas of the healthcare, life science and biotechnology industries.  Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking.

About NYSE Group, Inc
NYSE Group, Inc. (NYSE:NYX) operates two securities exchanges: the New York Stock Exchange LLC (the “NYSE”) and NYSE Arca, Inc. (formerly known as the Pacific Exchange). NYSE Group is a leading provider of securities listing, trading and market data products and services. In 2006, on an average trading day, 2.3 billion shares, valued at $86.8 billion, were traded on the exchanges of the NYSE Group.

The NYSE is the world’s largest and most liquid cash equities exchange. The NYSE provides a reliable, orderly, liquid and efficient marketplace where investors buy and sell listed companies’ common stock and other securities.  On December 31, 2006 , the operating companies listed on the NYSE represented a total global market capitalization of $25.0 trillion.

NYSE Arca, Inc. operates the former ArcaEx®, the first open, all-electronic stock exchange in the United States , which has a leading position in trading exchange-traded funds and exchange-listed securities. NYSE Arca, Inc. is also an exchange for trading equity options.  NYSE Arca, Inc.’s trading platforms provide customers with fast electronic execution and open, direct and anonymous market access.

NYSE Regulation, an independent not-for-profit subsidiary, regulates member organizations through the enforcement of marketplace rules and federal securities laws. NYSE Regulation also ensures that companies listed on the NYSE and NYSE Arca meet their financial and corporate governance listing standards.

For more information on NYSE Group, go to: www.nyse.com .

Cautionary Note Regarding Forward-Looking Statements
Certain statements in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on NYSE Group’s current expectations and involve risks and uncertainties that could cause NYSE Group’s actual results to differ materially from those set forth in the statements. There can be no assurance that such expectations will prove to be correct. Actual results may differ materially from those expressed or implied in the forward-looking statements. Factors that could cause NYSE Group’s results to differ materially from current expectations include, but are not limited to:  NYSE Group’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Group’s Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Group that the projections will prove to be correct. NYSE Group undertakes no obligation to release any revisions to any forward-looking statements.

 



Contact: Stephanie Scotto
Phone: 212.656.4896
Email:  sscotto@nyse.com